This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saito, A
Right arrow Articles by Suzuyama, Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saito, A
Right arrow Articles by Suzuyama, Y

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1985 July; 28(1): 15-20

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

A Saito, K Sawatari, Y Fukuda, M Nagasawa, H Koga, A Tomonaga, H Nakazato, K Fujita, Y Shigeno and Y Suzuyama

ABSTRACT

The antimicrobial activity of ofloxacin was tested against 15 standard strains and 37 clinical and environmental strains of Legionella pneumophila by agar dilution susceptibility studies with a new growth medium. The ofloxacin MICs were inoculum dependent and ranged from 0.03 to 0.125 microgram/ml. The antibacterial activities of other agents tested relative to ofloxacin were rifampin greater than ofloxacin greater than josamycin greater than pipemidic acid. Ofloxacin, at concentrations equal to or greater than 0.05 microgram/ml, inhibited the growth of L. pneumophila grown in human monocytes. The therapeutic efficacy of ofloxacin in experimental guinea pig L. pneumophila pneumonia was greater than that observed with erythromycin or josamycin therapy; it was less effective than was rifampin. Ofloxacin was very active against intracellular L. pneumophila in these experiments and should be studied in the therapy of human Legionnaires disease.

Antimicrob Agents Chemother. 1985 July; 28(1): 15-20




This article has been cited by other articles:

  • Almahmoud, I., Kay, E., Schneider, D., Maurin, M. (2009). Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila. J Antimicrob Chemother 64: 284-293 [Abstract] [Full Text]  
  • Sabria, M., Pedro-Botet, M. L., Gomez, J., Roig, J., Vilaseca, B., Sopena, N., Banos, V., for the Legionnaires Disease Therapy Group, (2005). Fluoroquinolones vs Macrolides in the Treatment of Legionnaires Disease. Chest 128: 1401-1405 [Abstract] [Full Text]  
  • Higa, F., Arakaki, N., Tateyama, M., Koide, M., Shinzato, T., Kawakami, K., Saito, A. (2003). In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.. J Antimicrob Chemother 52: 920-924 [Abstract] [Full Text]  
  • ARAKAKI, N., HIGA, F., KOIDE, M., TATEYAMA, M., SAITO, A. (2002). Induction of apoptosis of human macrophages in vitro by Legionella longbeachae through activation of the caspase pathway. J Med Microbiol 51: 159-168 [Abstract] [Full Text]  
  • Takemura, H., Yamamoto, H., Kunishima, H., Ikejima, H., Hara, T., Kanemitsu, K., Terakubo, S., Shoji, Y., Kaku, M., Shimada, J. (2000). Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila. J Antimicrob Chemother 46: 589-594 [Abstract] [Full Text]  
  • Smith, R. P., Baltch, A. L., Franke, M. A., Michelsen, P. B., Bopp, L. H. (2000). Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 45: 483-488 [Abstract] [Full Text]  
  • Lück, P. C., Schmitt, J. W., Hengerer, A., Helbig, J. H. (1998). Subinhibitory Concentrations of Antimicrobial Agents Reduce the Uptake of Legionella pneumophila into Acanthamoeba castellanii and U937 Cells by Altering the Expression of Virulence-Associated Antigens. Antimicrob. Agents Chemother. 42: 2870-2876 [Abstract] [Full Text]  
  • Schülin, T., Wennersten, C. B., Ferraro, M. J., Moellering, R. C. Jr., Eliopoulos, G. M. (1998). Susceptibilities of Legionella spp. to Newer Antimicrobials In Vitro. Antimicrob. Agents Chemother. 42: 1520-1523 [Abstract] [Full Text]  
  • Higa, F., Kusano, N., Tateyama, M., Shinzato, T., Arakaki, N., Kawakami, K., Saito, A. (1998). Simplified Quantitative Assay System for Measuring Activities of Drugs against Intracellular Legionella pneumophila. J. Clin. Microbiol. 36: 1392-1398 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»